Table 2.
LncRNAs as diagnosis biomarkers in liver diseases
| LncRNA | Feature | Cases | Control | Control condition | Sensitivity (%) |
Specificity (%) |
AUC |
|---|---|---|---|---|---|---|---|
| HULC | Up | 90 | 77 | HL | 0.78 | ||
| Linc00974 | Up | 150 | 150 | pre- and postoperative | 51.1 | 95.6 | 0.733 |
| UCA1 | Up | 82 | 44 | HL | 92.7 | 82.1 | 0.861 |
| Up | 82 | 34 | CHC | 61 | 71 | 0.728 | |
| Up | 34 | 44 | HL | 76.5 | 64.5 | 0.728 | |
| Up | 70 | 38 | HL | 91.4 | 88.6 | 0.91 | |
| Up | 70 | 32 | CHC | 71.4 | 87.5 | 0.838 | |
| Up | 32 | 38 | HL | 68.8 | 67.4 | 0.76 | |
| WRAP53 | Up | 82 | 44 | HL | 85.4 | 82.1 | 0.896 |
| Up | 82 | 34 | CHC | 85.4 | 71 | 0.787 | |
| Up | 34 | 44 | HL | 82.4 | 91 | 0.876 | |
| LINC01225 | Up | 66 | 70 | HL | 76.1 | 44.3 | 0.886 |
| DANCR | Up | 52 | 43 | HL/CHB/cirrhosis | 83.8 | 72.7 | 0.868 |
| Up | 52 | 29 | CHB | 80.8 | 84.3 | 0.864 | |
| JPX | Down | 42 | 68 | HL | 100 | 52.4 | 0.814 |
| MALAT1 | Up | 88 | 28 | hepatic disease | 51.1 | 89.3 | 0.66 |
| SPRY4‑IT1 | Up | 145 | 63 | HL | 87.3 | 50 | 0.702 |
| ENSG00000258332.1 | Up | 60 | 96 | CHB | 71.6 | 83.4 | 0.719 |
| LINC00635 | Up | 60 | 96 | CHB | 76.2 | 77.7 | 0.75 |
| LRB1 | Up | 326 | 73 | HL | 92.4 | 71.9 | 0.892 |
| D16366 | Down | 58 | 85 | HL | 65.5 | 84.6 | 0.752 |
| NONHSAT053785 | Up | 112 | 195 | CHB and HL | 73.2 | 74.4 | 0.801 |